Table 5.
Effects of anti-TNF-α and IgG during porcine oocyte in vitro maturation on subsequent embryonic development following IVF/IVC.
| Treatment | Cleaved embryos (n) |
Blastocyst development (n) |
Blastocyst/cleaved | Blastocyst cell number (n) |
|---|---|---|---|---|
| Control | 49.7 ± 3.3%ab (115) | 11.1 ± 1.7%a(115) | 23.7 ± 3.9%a | 59.2 ± 6.3 (12) |
| 100 µg/ml IgG | 64.0 ± 5.6%a (81) | 8.6 ± 1.8%ab(81) | 14.3 ± 3.1%ab | 47.7 ± 3.6 (8) |
| 100 µg/ml anti TNF | 47.0 ± 3.9%b (91) | 3.0 ± 1.5%b(91) | 5.3 ± 2.7%b | 45.5 ± 3.0 (4) |
ab
Different superscripts within a column denote significant difference, P < 0.05. Data are reported as mean ± SEM.